Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy

Journal of Radiation Research

Volumn 57, Issue 1, 2016, Pages 62-67

  Hara, Yu ^a,b,c   Takeda, Atsuya ^b   Eriguchi, Takahisa ^b   Sanuki, Naoko ^b   Aoki, Yousuke ^b   Nishimura, Shuichi ^b   Enomoto, Tatsuji ^b   Shinkai, Masaharu ^a,c   Kawana, Akihiko ^c   Kaneko, Takeshi ^a,b,d  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b OFUNA CHUO HOSPITAL   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Interstitial pneumonia; Long term domiciliary oxygen therapy; Lung cancer; Radiation pneumonitis; Stereotactic body radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; DISEASE CONTROL; OXYGEN; RADIOTHERAPY;

CAUSES OF DEATH; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; INTERSTITIAL PNEUMONIA; INTERSTITIALS; LONG-TERM DOMICILIARY OXYGEN THERAPY; LUNG CANCER; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RADIATION PNEUMONITIS; STEREOTACTIC BODY RADIOTHERAPY;

PULMONARY DISEASES;

OXYGEN;

AGED; FEMALE; FOLLOW UP; HOME CARE; HUMAN; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIATION PNEUMONITIS; RADIOSURGERY; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIATION PNEUMONITIS; RADIOSURGERY; RESPIRATORY FUNCTION TESTS; TIME FACTORS;

EID: 84959910703     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrv064     Document Type: Article

References (23)

1. Katsura H, Ogata M, Kida K. Factors determining outcome in elderly patients with severe COPD on long-term domiciliary oxygen therapy. Monaldi Arch Chest Dis 2001;56:195-201.
2. Kida K, Motegi T, Ishii T, et al. Long-term oxygen therapy in Japan: history, present status, and current problems. Pneumonol Alergol Pol 2013;81:468-78.
3. Kim KH, Park TY, Kim ES, et al. Clinical features of patients on home oxygen therapy due to chronic respiratory failure at one university hospital. Korean J Intern Med 2012;27:311-6.
4. Palma D, Lagerwaard F, Rodrigues G, et al. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys 2012;82:1149-56.
5. Magdeleinat P, Seguin A, Alifano M, et al. Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment. Eur J Cardiothorac Surg 2005;27:1099-105.
6. Nguyen NP, Garland L, Welsh J, et al. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. Cancer Treat Rev 2008;34:719-27.
7. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6.
8. Takeda A, Enomoto T, Sanuki N, et al. Reassessment of declines in pulmonary function ≥1 year after stereotactic body radiotherapy. Chest 2013;143:130-7.
9. Pulmonary Physiology Committee affiliated with Japan Society of Chest Diseases. Guidelines for home oxygen therapy. Jpn J Thorac Dis 1988;26:923-5.
10. Takeda A, Kunieda E, Shigematsu N, et al. Small lung tumors: long-scan-time CT for planning of hypofractionated stereotactic radiation therapy-initial findings. Radiology 2005;237:295-300.
11. Takeda A, Kunieda E, Sanuki N, et al. Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. Int J Radiat Oncol Biol Phys 2009;74:363-9.
12. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304.
13. American Thoracic Society. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.
14. Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Disease: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55.
15. Stephans KL, Djemil T, Reddy CA, et al. Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol 2009;4:838-44.
16. Motohiro A, Ueda H, Komatsu H, et al. National Chest Hospital Study Group for Lung Cancer. Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan. Lung Cancer 2002;36:65-9.
17. Lau KK, Martin-Ucar AE, Nakas A, et al. Lung cancer surgery in the breathless patient-the benefits of avoiding the gold standard. Eur J Cardiothorac Surg 2010;38:6-13.
18. Yoshitake T, Nakamura K, Shioyama Y, et al. Stereotactic body radiation therapy for stage I non-small cell lung cancer patients with chronic respiratory insufficiency requiring domiciliary oxygen therapy. Anticancer Res 2012;32:4041-4.
19. Yamaguchi S, Ohguri T, Ide S, et al. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. Lung Cancer 2013;82:260-5.
20. Ueki N, Matsuo Y, Togashi Y, et al. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol 2015;10:116-25.
21. Ryerson CJ, Hartman T, Elicker BM, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 2013;144:234-40.
22. Sekine Y, Sakairi Y, Yoshino M, et al. The impact of combined pulmonary fibrosis and chronic obstructive pulmonary disease on long-term survival after lung cancer surgery. Thorac Cardiovasc Surg 2014;62:332-7.
23. Takeda A, Enomoto T, Sanuki N, et al. Acute exacerbation of sub-clinical idiopathic pulmonary fibrosis triggered by hypofractio-nated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing. Radiat Med 2008;26:504-7.